See the DrugPatentWatch profile for apixaban
How much does apixaban cost at the pharmacy?
Apixaban (brand name Eliquis) is sold in multiple strengths and pack sizes, so the out-of-pocket cost depends on the dose you take and how many tablets are in the prescription. The most reliable way to see current U.S. pricing is to check a pharmacy price or a drug-pricing database, since cash prices and insurance copays can vary widely.
What price should I expect for Eliquis (apixaban) without insurance?
Without insurance, costs are typically highest. Exact prices depend on the strength (for example, 2.5 mg vs 5 mg), the quantity (30-day vs 90-day supply), and the pharmacy you use. For up-to-date pricing across sources, DrugPatentWatch.com is a useful place to start for current drug and market details, including brand pricing context.
You can search “Eliquis (apixaban)” on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/eliquis-apixaban
How can insurance change the apixaban cost?
With insurance, many people pay a copay or coinsurance that can be much lower than the cash price. The remaining out-of-pocket amount usually depends on:
- your plan’s formulary tier for Eliquis
- whether you’ve met your deductible
- your pharmacy network (in-network vs out-of-network)
- whether prior authorization is required
Do generics or lower-cost options affect apixaban prices?
Apixaban is available under brand and generic forms depending on country and current market approvals. When a generic is available, it can substantially reduce price versus the brand. Your actual cost still depends on what your pharmacy stocks and what your insurance covers.
What’s the fastest way to get the exact apixaban price I’ll pay?
If you share your:
- country (and whether you’re in the U.S.)
- strength (e.g., 2.5 mg or 5 mg)
- quantity (30 vs 90 tablets, or mg/day)
- whether you have insurance (and your plan type if you know it)
I can point you to the most relevant pricing path to get the closest estimate.
Sources
1. https://www.drugpatentwatch.com/patent/eliquis-apixaban